- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x 507: 1-{3-[6-(tetrahydro-2H-pyran-4-ylamino)imidazo[1,2-b]pyridazin-3-yl]phenyl}ethanone(Non-covalent)
507.3: 16 residues within 4Å:- Chain A: V.16, G.17, Y.21, V.24, A.35, L.65, T.85, H.86, Y.87, H.88, G.91, K.142, N.143, L.145, A.155, D.156
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.16, A:A.35, A:L.65, A:Y.87, A:L.145, A:A.155
- Hydrogen bonds: A:H.88
- Water bridges: A:V.16, A:K.37
507.21: 16 residues within 4Å:- Chain B: V.16, G.17, Y.21, V.24, A.35, L.65, T.85, H.86, Y.87, H.88, G.91, K.142, N.143, L.145, A.155, D.156
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:V.16, B:A.35, B:L.65, B:Y.87, B:L.145, B:A.155
- Hydrogen bonds: B:H.88
- Water bridges: B:V.16, B:K.37
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 3 residues within 4Å:- Chain A: K.140, T.180
- Ligands: PO4.1
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: H.61, H.120, I.123, K.294
- Ligands: EDO.18
Ligand excluded by PLIPEDO.6: 8 residues within 4Å:- Chain A: H.61, E.62, I.64, L.65, G.66, H.86, H.88, C.153
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: R.182, Y.234, V.237, P.238, N.239
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: R.203, P.284, S.285, R.287
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: E.44, K.45, F.48
- Chain B: E.44, K.45, F.48
- Ligands: EDO.27
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: S.41, E.44, T.79, L.81
- Chain B: F.48
Ligand excluded by PLIPEDO.11: 1 residues within 4Å:- Chain A: H.76
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: K.45
- Chain B: K.45, N.174
- Ligands: EDO.30
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: P.132, M.162, H.163, S.164, Q.169, D.171
Ligand excluded by PLIPEDO.14: 1 residues within 4Å:- Chain A: C.197
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: Y.94, Q.98, Y.229, P.231
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain A: I.123, K.202, T.289, A.290, L.291
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain A: S.70, D.71, M.72
- Chain B: T.51, N.55, S.70
- Ligands: EDO.35
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: H.61, N.63, S.116, K.294
- Ligands: EDO.5
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain B: K.140, T.180
- Ligands: PO4.19
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain B: H.61, H.120, I.123, K.294
- Ligands: EDO.36
Ligand excluded by PLIPEDO.24: 8 residues within 4Å:- Chain B: H.61, E.62, I.64, L.65, G.66, H.86, H.88, C.153
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: R.182, Y.234, V.237, P.238, N.239
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: R.203, P.284, S.285, R.287
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain A: E.44, K.45, F.48
- Chain B: E.44, K.45, F.48
- Ligands: EDO.9
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain A: F.48
- Chain B: S.41, E.44, T.79, L.81
Ligand excluded by PLIPEDO.29: 1 residues within 4Å:- Chain B: H.76
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain A: K.45, N.174
- Chain B: K.45
- Ligands: EDO.12
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain B: P.132, M.162, H.163, S.164, Q.169, D.171
Ligand excluded by PLIPEDO.32: 1 residues within 4Å:- Chain B: C.197
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain B: Y.94, Q.98, Y.229, P.231
Ligand excluded by PLIPEDO.34: 5 residues within 4Å:- Chain B: I.123, K.202, T.289, A.290, L.291
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain A: T.51, N.55, S.70
- Chain B: S.70, D.71, M.72
- Ligands: EDO.17
Ligand excluded by PLIPEDO.36: 5 residues within 4Å:- Chain B: H.61, N.63, S.116, K.294
- Ligands: EDO.23
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chaikuad, A. et al., Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor K00507. To be Published
- Release Date
- 2010-10-13
- Peptides
- Activin receptor type-1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
SMTL ID : 3oom.1
Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor K00507
Activin receptor type-1
Toggle Identical (AB)Related Entries With Identical Sequence
3mtf.1 | 3mtf.2 | 3q4u.1 | 3q4u.2 | 3q4u.3 | 4bgg.1 | 4bgg.2 | 4bgg.3 | 4bgg.4 | 5oxg.1 | 5oxg.2 | 5oxg.3 | 5oxg.4 | 5oy6.1 | 5oy6.2 | 5oy6.3 | 5oy6.4 | 5s75.1 | 5s75.2 | 5s76.1 | 5s76.2 | 5s77.1 | 5s77.2 | 5s78.1 | 5s78.2 | 5s79.1 | 5s79.2 | 5s7a.1 | 5s7a.2 | 5s7b.1 more...less...5s7b.2 | 5s7c.1 | 5s7c.2 | 5s7d.1 | 5s7d.2 | 5s7e.1 | 5s7e.2 | 5s7f.1 | 5s7f.2 | 5s7g.1 | 5s7g.2 | 5s7h.1 | 5s7h.2 | 5s7i.1 | 5s7i.2 | 5s7j.1 | 5s7j.2 | 5s7k.1 | 5s7l.1 | 5s7m.1 | 5s7n.1 | 5s7o.1 | 5s7o.2 | 5s7p.1 | 5s7p.2 | 5s7q.1 | 5s7r.1 | 5s7r.2 | 5s7s.1 | 5s7s.2 | 5s7t.1 | 5s7u.1 | 5s7v.1 | 5s7v.2 | 5s7w.1 | 5s7x.1 | 5s7x.2 | 5s7y.1 | 5s7z.1 | 5s7z.2 | 5s80.1 | 5s80.2 | 5s81.1 | 5s82.1 | 5s83.1 | 5s84.1 | 5s85.1 | 5s86.1 | 5s87.1 | 5s87.2 | 5s88.1 | 5s88.2 | 5s89.1 | 5s89.2 | 5s8a.1 | 5s8b.1 | 5s9k.1 | 6gi6.1 | 6gin.1 | 6gip.1 | 6srh.1 | 6srh.2 | 6szm.1 | 6szm.2 | 6t6d.1 | 6t6d.2 | 6t6d.3 | 6t6d.4 | 6t8n.1 | 6t8n.2 | 6tn8.1 | 6z36.1 | 6z36.2 | 6zgc.1 | 6zgc.2 | 6zgc.3 | 6zgc.4 | 7a21.1 | 7a21.2 | 7nns.1 | 8c7w.1 | 8c7z.1 | 8r7g.1 | 8r7g.2 | 8r7g.3 | 8r7g.4